The Norwich-based drug discovery startup emerged from stealth with backing from SynBioVen, Start Codon, UKI2S, Twin Path Ventures, Wren Capital, angels, and Innovate UK.
"We grow greener medicines using a platform that makes the impossible accessible. The drug discovery field desperately needs new chemical space and the vaccine field needs new adjuvants, with supply chains that work for everyone. By combining AI with plant engineering, we can reach molecules others cannot, and scale them in a way that supports global health, not just high-income markets."
Twin Path Ventures led the pre-seed round to accelerate the rollout of the artificial intelligence game creation platform.
"We want to empower creatives and storytellers to embrace the potential of AI-supported narrative game creation. It’s the future of gamemaking, and we’re at the forefront of making its possibilities a reality."
Notion Capital led the Series B round to support the company expansion across North America, APAC, and Europe.
"Our world runs on nature-based commodities, yet information on the physical source of these assets remains largely invisible to the systems that depend on them. Data informs the flow of capital, and at Treefera we equip enterprises with the clarity to strengthen supply chain resilience, secure future revenue, and scale the upside of regenerative practices. With defensible real-time insights on commodities, ingredients and carbon from the first-mile, businesses can not only have clearer sightlines into sourcing but mitigate risk and ensure compliance. This backing led by Notion Capital enables us to accelerate our mission globally for the benefit of business and planet."